2024年12月17日,Quanterix,一家通过超灵敏生物标记物检测推动科学发现和突破性诊断的公司(纳斯达克股票代码:QTRX)宣布收购EMISSION iNC. (“EMISSION”)。Quanterix 预计该交易将于2025年1月完成。Quanterix的Simoa数字免疫测定技术以超灵敏著称,能够实现远低于传统ELISA这种模拟方法的定量限 (LoQ),有助于血液、血清或血浆中早期低...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.